Currently holds a position at Xenon Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Executive Officer, Director | Xenon Pharmaceuticals Inc | March 12, 2018 - |
President, Chief Executive Officer, Director | Xenon Pharmaceuticals Inc | Jan. 1, 2003 - March 12, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-06-01 | 2023-06-01 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
24,255
-80.2%
38.78940,609 USD |
24,255 -80.2% | 38.78 | 940,609 USD | |
2023-06-01 | 2023-06-01 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
7,458
-55.4%
38.97290,638 USD |
7,458 -55.4% | 38.97 | 290,638 USD | |
2023-06-01 | 2023-05-31 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
26,856
-81.7%
38.691,039,059 USD |
26,856 -81.7% | 38.69 | 1,039,059 USD | |
2023-06-01 | 2023-05-31 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
23,670
-79.8%
38.81918,633 USD |
23,670 -79.8% | 38.81 | 918,633 USD | |
2023-06-01 | 2023-05-31 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
12,000
-66.7%
38.53462,360 USD |
12,000 -66.7% | 38.53 | 462,360 USD | |
2023-06-01 | 2023-05-30 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
19,000
-51.4%
39.90758,100 USD |
19,000 -51.4% | 39.90 | 758,100 USD | |
2023-06-01 | 2023-05-30 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
18,006
-32.7%
38.63695,572 USD |
18,006 -32.7% | 38.63 | 695,572 USD | |
2023-03-09 | 2023-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
8,242
-13.0%
36.94304,459 USD |
8,242 -13.0% | 36.94 | 304,459 USD | |
2023-03-09 | 2023-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
10,990
-24.4%
37.01406,740 USD |
10,990 -24.4% | 37.01 | 406,740 USD | |
2022-08-16 | 2022-08-16 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
20,000
-76.9%
38.87777,400 USD |
20,000 -76.9% | 38.87 | 777,400 USD | |
2022-08-16 | 2022-08-16 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
32,058
-55.2%
38.291,227,501 USD |
32,058 -55.2% | 38.29 | 1,227,501 USD | |
2022-08-16 | 2022-08-15 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
33,942
-36.9%
37.761,281,650 USD |
33,942 -36.9% | 37.76 | 1,281,650 USD | |
2022-08-16 | 2022-08-12 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
1,000
-1.1%
39.1539,150 USD |
1,000 -1.1% | 39.15 | 39,150 USD | |
2022-08-16 | 2022-08-12 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
47,000
-33.6%
38.601,814,200 USD |
47,000 -33.6% | 38.60 | 1,814,200 USD | |
2022-08-16 | 2022-08-12 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
43,135
-23.6%
37.911,635,248 USD |
43,135 -23.6% | 37.91 | 1,635,248 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
2,500
-1.3%
30.5076,250 USD |
2,500 -1.3% | 30.50 | 76,250 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
2,500
-1.3%
30.5576,375 USD |
2,500 -1.3% | 30.55 | 76,375 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
2,500
-1.3%
30.2075,500 USD |
2,500 -1.3% | 30.20 | 75,500 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
2,500
-1.3%
30.1075,250 USD |
2,500 -1.3% | 30.10 | 75,250 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
2,500
-1.3%
3.809,500 USD |
2,500 -1.3% | 3.80 | 9,500 USD | |
2022-03-08 | 2022-03-08 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
2,051
-1.0%
30.6062,761 USD |
2,051 -1.0% | 30.60 | 62,761 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
2,500
-1.2%
30.5576,375 USD |
2,500 -1.2% | 30.55 | 76,375 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
7,500
-3.6%
30.50228,750 USD |
7,500 -3.6% | 30.50 | 228,750 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
2,500
-1.2%
30.5276,300 USD |
2,500 -1.2% | 30.52 | 76,300 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
4,516
-2.1%
30.44137,467 USD |
4,516 -2.1% | 30.44 | 137,467 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
4,516
-2.1%
30.45137,512 USD |
4,516 -2.1% | 30.45 | 137,512 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
4,517
-2.0%
30.49137,723 USD |
4,517 -2.0% | 30.49 | 137,723 USD | |
2022-03-08 | 2022-03-07 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
5,037
-2.2%
30.60154,132 USD |
5,037 -2.2% | 30.60 | 154,132 USD | |
2022-03-08 | 2022-03-04 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
4,793
-2.2%
30.56146,474 USD |
4,793 -2.2% | 30.56 | 146,474 USD | |
2022-03-08 | 2022-03-04 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
4,532
-2.1%
30.66138,951 USD |
4,532 -2.1% | 30.66 | 138,951 USD | |
2021-11-16 | 2021-11-15 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
17,557
-7.7%
31.33550,061 USD |
17,557 -7.7% | 31.33 | 550,061 USD | |
2020-06-02 | 2020-06-01 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
3,000
-1.2%
14.4343,290 USD |
3,000 -1.2% | 14.43 | 43,290 USD | |
2020-06-02 | 2020-05-29 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
5,000
-1.9%
13.9969,950 USD |
5,000 -1.9% | 13.99 | 69,950 USD | |
2019-09-24 | 2019-09-20 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
10,395
-3.9%
9.5198,856 USD |
10,395 -3.9% | 9.51 | 98,856 USD |